Na­maste ac­quires do­main, cus­tomers of VapeBr

Na­maste Tech­nolo­gies Inc. has ac­quired the do­main and cus­tomer data­base of VapeBr, Brazil’s largest va­por­izer re­tailer.

Stockwatch Daily - - FRONT PAGE - Mr. Sean Dollinger re­ports

NA­MASTE TECH­NOLO­GIES Inc. has ac­quired the do­main and cus­tomer data­base of Brazil’s largest va­por­izer re­tailer, VapeBr, in con­sid­er­a­tion of sign­ing an ex­clu­sive ser­vices agree­ment for ful­fil­ment for Na­maste’s Brazil­ian op­er­a­tions. The ac­qui­si­tion of VapeBr is ac­cre­tive in na­ture and is ex­pected to add over $1-mil­lion in ad­di­tional an­nual rev­enue to Na­maste’s cur­rent rev­enue stream.

Un­der the terms of the agree­ment, Na­maste has ac­quired the VapeBr do­main and will there­fore in­herit all fu­ture as­so­ci­ated rev­enue.

VapeBr man­age­ment has agreed to pro­vide the fol­low­ing un­der the agree­ment:

• In­ven­tory man­age­ment;

• Or­der pro­cess­ing;

• Lo­cal sup­port;

• War­ranty/re­turn pro­cess­ing.

As a re­sult of this trans­ac­tion, Na­maste plans to greatly ex­pand the VapeBr prod­uct of­fer­ing, as it sees very strong growth po­ten­tial in the Brazil­ian mar­ket. The ac­qui­si­tion of the VapeBr e-com­merce plat­form is not only ex­pected to have an im­me­di­ate im­pact on Na­maste’s rev­enue, but it is also ex­pected to add over 10,000 ad­di­tional cus­tomers to Na­maste’s grow­ing global data­base of med­i­cal cannabis users. Through the in­te­gra­tion of VapeBr onto Na­maste’s proven e-com­merce plat­form, Na­maste is con­fi­dent it can sub­stan­tially grow this al­ready im­pres­sive cus­tomer base. This agree­ment fur­ther val­i­dates Na­maste’s abil­ity to con­sol­i­date in­dus­try com­peti­tors and ex­pand its op­er­a­tions abroad.

Ad­di­tion­ally, Na­maste is pleased to an­nounce that the Na­mas­teMD smart phone app has been sub­mit­ted to the Ap­ple Store, is await­ing ap­proval, and is ex­pected to soon be avail able on b oth IOS and An­droid de­vices. Na­mas­teMD is a rev­o­lu­tion­ary telemedicine ap­pli­ca­tion which has been de­signed to con­nect pa­tients with doc­tors and nurse prac­ti­tion­ers, in an at­tempt to fa­cil­i­tate a seam­less process for ob­tain­ing med­i­cal doc­u­ments un­der Canada’s Ac­cess to Cannabis for Med­i­cal Pur­poses Reg­u­la­tions (ACMPR) pro­gram. This state-of-the-art ap­pli­ca­tion in­cor­po­rates fa­cial recog­ni­tion al­go­rithms, and is the first of its kind to fea­ture ex­clu­sive age- and iden­tity-ver­i­fi­ca­tion tech­nol­ogy. Na­maste plans on uti­liz­ing this tech­nol­ogy on the Na­mas­teMD plat­form to dis­trib­ute medic­i­nal cannabis through its wholly owned sub­sidiary, Can­n­mart Inc. Man­age­ment com­men­tary Sean Dollinger, pres­i­dent and chief ex­ec­u­tive of­fi­cer of Na­maste, com­mented: “I am ex­tremely proud of our team for build­ing an e-com­merce plat­form that is be­ing ac­tively so­licited by our di­rect com­peti­tors to work col­lab­o­ra­tively. Based on this agree­ment, we ex­pect fur­ther op­por­tu­ni­ties to present them­selves for Na­maste to work with com­pa­nies look­ing to di­vest their busi­nesses, and be­lieve such ar­range­ments are a win-win sit­u­a­tion for all par­ties in­volved. We are ex­tremely ex­cited that our ef­forts are not only be­ing no­ticed but re­warded with ar­range­ments as such. Na­maste wel­comes these op­por­tu­ni­ties and an­tic­i­pates these trends to con­tinue as Na­maste steals mar­ket share on a global scale. This trans­ac­tion fur­ther con­firms the value we have cre­ated with re­gards to the prod­ucts and ser­vices we pro­vide, and our abil­ity to lever­age our data­base mov­ing for­ward.

“As our e-com­merce plat­form evolves, we are con­fi­dent our de­ci­sion to im­ple­ment cut­ting-edge age­and iden­tity-ver­i­fi­ca­tion tech­nol­ogy ahead of our com­pe­ti­tion will be in­stru­men­tal in al­low­ing us to be­come in­dus­try lead­ers. We be­lieve these in­no­va­tive ini­tia­tives not only demon­strate our com­mit­ment to the in­dus­try, but also pro­vide an ideal so­lu­tion to en­sure the safe and re­spon­si­ble dis­tri­bu­tion of recre­ational cannabis on both a pro­vin­cial and fed­eral level.”

About Na­maste Tech­nolo­gies Inc.

Na­maste is the largest on-line re­tailer for med­i­cal cannabis de­liv­ery sys­tems glob­ally. Na­maste dis­trib­utes va­por­iz­ers and smok­ing ac­ces­sories through e-com­merce sites in 26 coun­tries and with five dis­tri­bu­tion hubs lo­cated around the world. Na­maste has ma­jor­ity mar­ket share in Europe and Aus­tralia, with op­er­a­tions in the United King­dom, United States, Canada and Ger­many and has opened new sup­ply chan­nels into emerg­ing mar­kets in­clud­ing Brazil, Mex­ico and Chile. Na­maste, through its ac­qui­si­tion of Can­n­mart Inc., a Cana­dian-based late-st age ap pli cant for a med­i­cal cannabis dis­tri­bu­tion li­cence (un­der the Ac­cess to Cannabis for Med­i­cal Pur­poses Reg­u­la­tions), is pur­su­ing a new rev­enue ver­ti­cal in on-line re­tail of med­i­cal cannabis in the Cana­dian mar­ket.

We seek Safe Har­bor.

Sean Dollinger, Sefi Dollinger, Ki­ran Sidhu, Peter Em­manouil Simeon, Philip van den Berg

(N) Shares: 202,628,131

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.